BAI-3 inhibitors belong to a class of chemical compounds that have attracted attention in the field of molecular biology and cellular signaling research. These inhibitors are specifically designed to target and modulate the activity of BAI-3, which stands for Brain-specific angiogenesis inhibitor 3. BAI-3 is a member of the adhesion G protein-coupled receptor (aGPCR) family, a diverse group of cell surface receptors that have roles in various physiological processes. BAI-3, in particular, is expressed predominantly in the brain and is known for its involvement in angiogenesis, the process of forming new blood vessels, as well as its role in neural development and synaptic plasticity.
BAI-3 inhibitors exert their effects by interfering with the signaling pathways initiated by BAI-3 activation, disrupting its roles in angiogenesis and neural processes. This interference can lead to alterations in cellular responses to extracellular cues and may impact processes such as blood vessel formation and synaptic remodeling. Researchers employ BAI-3 inhibitors as valuable tools to investigate the specific roles of BAI-3 in different cellular contexts, particularly in the brain, and to gain insights into the molecular mechanisms governing cellular responses to angiogenic signals and neuronal development. While the precise applications and broader implications of BAI-3 inhibitors continue to be subjects of ongoing research, their utility in elucidating the complexities of aGPCR signaling and its impact on cellular processes is of paramount importance in advancing our understanding of molecular and cell biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially reducing overall mRNA levels including that of BAI-3. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can lead to altered protein synthesis and could decrease the expression of proteins like BAI-3. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Alkylates DNA and could cause downregulation of gene transcription, potentially affecting BAI-3 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step, possibly reducing BAI-3 protein levels. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis, which could decrease BAI-3 protein levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to altered signaling pathways, possibly affecting BAI-3 expression indirectly. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to inhibit lysosomal activity and autophagy which could influence cellular protein levels including BAI-3. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression through retinoic acid receptors, potentially modulating the expression of proteins like BAI-3. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Dihydrofolate reductase inhibitor, affecting nucleotide synthesis and potentially downregulating BAI-3 gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor that can cause changes in chromatin structure and influence gene expression, including BAI-3. | ||||||